Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BiltRx vs Wisp

BiltRx
Graded #58

Level

vs
Wisp
Graded #59

Level

The verdict

Too close to call — both grade 75/100 (C).

BiltRx and Wisp land on the same WeighScore, so neither clears the other on our six graded dimensions. BiltRx sits one line higher on the board (#58 vs #59) on the underlying tiebreak, but it's a genuine coin-flip — pick on the factors and prices that matter most to you below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBiltRx +7
90
83
Dose & formulationWisp +3
85
88
Clinical oversightWisp +8
74
82
Labs & monitoringWisp +1
52
53
FulfillmentBiltRx +5
71
66
Contract termsEven
55
55
BiltRx · left barWisp · right bar

The numbers

MetricBiltRxWisp
WeighScore75/10075/100
GradeCC
Scorecard rank#58#59
Semaglutide$125/mo (all doses, compounded)$225/mo (compounded oral)
Tirzepatide$129/mo (all doses, compounded)$99/mo (starting dose, brand-name)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
BiltRx

Graded #58 · C

Strengths

  • Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
  • LegitScript verified and HIPAA compliant
  • Names its 503A compounding pharmacies (Boothwyn and Southend)
  • Offers both compounded and brand-name GLP-1 options

Where it loses points

  • Covered states are behind a check-availability gate, not listed
  • Starting prices may rise depending on plan and dose
Wisp

Graded #59 · C

Strengths

  • Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
  • LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
  • Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary

Where it loses points

  • Sublingual compounded semaglutide hasn't been tested in humans, per Wisp's own page — only the injectables have FDA efficacy data
  • Pharmacy partners not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard